about
Using prescription claims data for drugs available over-the-counter (OTC).Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm.Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposureAdministrative data algorithms to identify second breast cancer events following early-stage invasive breast cancerAge, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancerImpact of bipolar disorder: results from a screening study.Breast cancer treatment of older women in integrated health care settings.Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.Use of prescription medications with a potential for fetal harm among pregnant women.Under utilization of surveillance mammography among older breast cancer survivors.Mammography surveillance and mortality in older breast cancer survivors.Long-term safety of radiotherapy and breast cancer laterality in older survivors.Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrenceA most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancerMulticenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics.Epidemiologic study of aripiprazole use and the incidence of suicide events.Using probabilistic corrections to account for abstractor agreement in medical record reviews.The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer.Maternal zinc and fetal neural tube defects.Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.Mortality impact of less-than-standard therapy in older breast cancer patients.Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts.Patterns and characteristics of repeat mammography among women 50 years and older.Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer.Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.Receipt of Appropriate Primary Breast Cancer Therapy and Adjuvant Therapy Are Not Associated With Obesity in Older Women With Access to Health CareRecurrences and second primary breast cancers in older women with initial early-stage diseasePatterns and predictors of mammography utilization among breast cancer survivorsBarriers to the initiation of, and persistence with, insulin therapyRe: Breast Cancer Screening Comes Full CircleLate-Stage Breast Cancer Among Women With Recent Negative Screening Mammography: Do Clinical Encounters Offer Opportunity for Earlier Detection?Processes of care in cervical and breast cancer screening and follow-up—the importance of communicationApprovable Letters in the FDA New Drug Approval ProcessComparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodoneCancer trends unique to Georgia
P50
Q31119847-2C44518A-DE42-42D6-9FEA-ACBA629C9909Q31140382-CAD6D28A-8A1E-4291-A637-C719E7BCFF0FQ34159971-F2FB1045-E7F3-4DDA-AC04-452B46AD21B6Q34252411-54A0B98C-CB80-44E3-8D8D-CC3695991A1FQ35570862-66CC4D4A-216C-4D3C-BD11-F8C4010622CBQ35847010-8531EB11-9261-4D67-82E8-D791CF384698Q35879504-B0BDC140-8B23-4E12-A3F4-00E6A85B90CAQ36207305-2C6DED85-283B-4B25-9AB1-BC0E791E214AQ36439787-A4144A47-CCC0-4F32-9BCA-556CBD579269Q36607255-250C43BD-333E-4B4C-83DD-9D10BCE03107Q36840462-F31B4D4F-C7B4-4784-AA35-57D9D41CB3C1Q37200581-88B64CE8-D8E2-4E99-BF97-03E1166FA8AEQ37369805-A7FCD200-9F7A-466C-9F4D-2C91D7613C4AQ37461037-60523CE0-1A42-42C7-B094-CE159B49D342Q41404755-FDCF744A-7E2B-447F-B42D-C71DFBA28AA6Q42668149-745F48A7-1163-4E1B-9A4D-FA9B14361F6DQ42868719-4ABDB0FA-189D-42C1-A575-A1ADFE2F68D2Q43457063-56E777C8-5A5D-438D-80B7-7CDDEA1F2D51Q43902026-6D24D54F-9423-4327-AB7B-36F826605190Q44064200-A65DA5A0-72A8-4416-AA0F-AE40E806D834Q45403597-37276CF4-0E83-42F2-BEF7-96DEE21B9345Q46835873-3B200222-7106-4437-9657-15BAEB192321Q46856810-F3712A24-95C0-4681-9193-A53F5E6771DFQ50121506-B8553444-E2F7-4CAB-835B-CCD3B14B6053Q50650178-7C196C7D-8613-4EB3-B891-D9CBC819B828Q51832306-15229390-016B-47EB-89FF-47435B6B72DDQ53022877-C573FBC2-6FF0-4D7F-A5A0-82808EB9920AQ59176621-C60C9D4A-C2C7-4819-912D-3BD8616C4335Q59176625-05D4FC81-F738-4C05-8933-F53BEEE91996Q59349512-266D8C6F-C121-48E7-A097-3B5B0600F638Q60622468-2933E303-EC0B-4EEA-B3B6-C39778CFDC41Q60622482-4608FD97-C12F-461F-AA66-75003F1CCDD6Q60622484-6B83D2D5-CB17-434D-BB04-3EFF46144E83Q60622489-CDFB310E-045A-4FF1-8DD7-8F4CA3A2A1E3Q60622499-71DDD03C-3B5B-47C2-8241-AE4BB28B74FBQ68000231-8A73DECA-D02C-45E8-9766-30154CD75210Q70637136-D1AA6C73-5E89-4F5F-ABCC-C1CAA6F5A175
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marianne Ulcickas Yood
@ast
Marianne Ulcickas Yood
@en
Marianne Ulcickas Yood
@es
Marianne Ulcickas Yood
@sl
type
label
Marianne Ulcickas Yood
@ast
Marianne Ulcickas Yood
@en
Marianne Ulcickas Yood
@es
Marianne Ulcickas Yood
@sl
prefLabel
Marianne Ulcickas Yood
@ast
Marianne Ulcickas Yood
@en
Marianne Ulcickas Yood
@es
Marianne Ulcickas Yood
@sl
P106
P21
P31
P496
0000-0003-4204-0871